• Pay My Bill
  • Careers
  • Donate
  • My Health Record
  • +1 (401) 274-1100

Site Search

Dr. Melissa Russo named to one international, two national organizations

Release Date: 07/13/2018

Melissa Russo, MD, a maternal-fetal medicine and clinical genetics specialist in the Division of Maternal-Fetal Medicine at Women & Infants Hospital of Rhode Island, a Care New England hospital, has recently been appointed to three professional organizations and committees. She is also an assistant professor of obstetrics and gynecology at The Warren Alpert Medical School of Brown University and a member of Care New England Medical Group.

Dr. Russo has been named to a three-year term of the Genetics Committee of the American College of Obstetricians and Gynecologists; a three-year term on the Professional Advisory Board of the Marfan Foundation; and a nominated member of the International Research Society for Genetic Aortic Disease, the Montalcino Aortic Consortium, a consortium of prominent clinical, basic, and translational investigators around the world committed to diagnosing and managing aortic disorders and discovering their genetic causes and modifiers.

“Marfan Syndrome is a connective tissue disorder that affects the blood vessels, leaving individuals with a genetic predisposition for aortic dissections. The work of these two organizations is crucial to ensuring early diagnosis and proper treatment that can save the lives of mothers and babies,” said Dr. Russo. “I am deeply honored to represent my specialty and Women & Infants Hospital with these prestigious organizations.”

A magna cum laude graduate of Colgate University, Dr. Russo earned her medical degree from Georgetown University School of Medicine. She completed her residency in obstetrics and gynecology and fellowship in maternal-fetal medicine and clinical genetics at Johns Hopkins University.

Dr. Russo is board certified in obstetrics and gynecology, maternal-fetal medicine, and genetics. Prior to joining Women & Infants, she was at Texas Children’s/Baylor University in Houston, TX, where she was an assistant professor of maternal-fetal medicine and human and molecular genetics. Her research interests include prenatal genetics, reproductive and pregnancy outcomes in women with connective tissue disorders such as Marfan syndrome and Loeys-Dietz syndrome.

Dr. Russo performs pre-conception and pregnancy genetic consultations at the Maternal-Fetal Medicine Clinic of Women & Infants, (401) 274-1122, ext. 47096.

 

 

About Women & Infants Hospital 

Women & Infants Hospital of Rhode Island, a Care New England hospital, is one of the nation’s leading specialty hospitals for women and newborns. A major teaching affiliate of The Warren Alpert Medical School of Brown University for obstetrics, gynecology and newborn pediatrics, as well as a number of specialized programs in women’s medicine, Women & Infants is the 9th largest stand-alone obstetrical service in the country and the largest in New England with approximately 8,500 deliveries per year. A Designated Baby-Friendly® USA hospital, U.S.News & World Report 2014-15 Best Children’s Hospital in Neonatology and a 2014 Leapfrog Top Hospital, in 2009 Women & Infants opened what was at the time the country’s largest, single-family room neonatal intensive care unit.

Women & Infants and Brown offer fellowship programs in gynecologic oncology, maternal-fetal medicine, urogynecology and reconstructive pelvic surgery, neonatal-perinatal medicine, pediatric and perinatal pathology, gynecologic pathology and cytopathology, and reproductive endocrinology and infertility. It is home to the nation’s first mother-baby perinatal psychiatric partial hospital, as well as the nation’s only fellowship program in obstetric medicine.

Women & Infants has been designated as a Breast Imaging Center of Excellence by the American College of Radiography; a Center of Excellence in Minimally Invasive Gynecology; a Center of Biomedical Research Excellence by the National Institutes of Health (NIH); and a Neonatal Resource Services Center of Excellence. It is one of the largest and most prestigious research facilities in high risk and normal obstetrics, gynecology and newborn pediatrics in the nation, and is a member of the National Cancer Institute’s Gynecologic Oncology Group and the Pelvic Floor Disorders Network.